Insider · CIK 0001410830

Matrix Capital Management Company, LP

owner

Files at ZNTL (Zentalis Pharmaceuticals, Inc.). First filing Dec 15, 2025, latest Dec 15, 2025.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

0 / 1

$0 bought, $10.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ZNTL: Zentalis Pharmaceuticals, Inc.

ZNTLOct 9, 2026 · close 2.64

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
57Moderate	ZNTLsell Zentalis Pharmaceuticals, Inc.	$10.0M 7,500,000 shares	-54%	+35% from low-57% from high	Dec 15, 2025

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Dec 15, 2025	ZNTL Zentalis Pharmaceuticals, Inc.	SOpen-market sale Common Stock, par value $0.001 per shareindirect: See footnotes	-7,500,000	$1.33	$10.0M	6,459,973	Dec 15, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.